Science Explorer Interactive view Map
Company · Guangzhou · China

Regenex Pharmaceuticals (China)

Research works
40
▲ 82% vs 2013–17
Citations
432
10.9 per fractional work
Top-10% rate
18.9%
record average 16.5%
Open access
38%
world 28%

Not ranked overall: Regenex Pharmaceuticals (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.14× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.04× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 5.51× its world share, 1 worksImmunology and Micro…Neuroscience: 0.56× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 15.82× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 2.59× its world share, 0 worksChemical EngineeringChemistry: 2.41× its world share, 1 worksChemistryComputer Science: 0.40× its world share, 1 worksComputer ScienceEnergy: 0.98× its world share, 0 worksEnergyEngineering: 0.78× its world share, 2 worksEngineeringEnvironmental Science: 0.24× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.73× its world share, 1 worksMaterials ScienceHealth Professions: 0.17× its world share, 0 worksHealth ProfessionsMedicine: 1.68× its world share, 6 worksMedicineDecision Sciences: 0.62× its world share, 0 worksDecision Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 15.8×. Every wedge is a field page.

Which keywords describe research at Regenex Pharmaceuticals (China)?

By fractional works in all years, weighted toward what it does more of than the world: Antioxidant, Cancer, Pharmacology, Inflammation, Gene Therapy, Anti-inflammatory, Herbal Medicine and Microneedles.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Antioxidant4▲ 16×16 topics
  2. Cancer4▲ 6.7×16 topics
  3. Inflammation4▲ 4.0×20 topics
  4. Pharmacology3▲ 22×9 topics
  5. Nanoparticles2▲ 4.0×9 topics
  6. Gene Therapy2▲ 19×4 topics
  7. Anti-inflammatory2▲ 17×10 topics
  8. Herbal Medicine2▲ 20×3 topics
  9. Antiviral2▲ 46×3 topics
  10. Microneedles2▲ 193×1 topic
  11. Solid Lipid Nanoparticles2▲ 193×1 topic
  12. Bioactive Compounds2▲ 21×3 topics
  13. Glycosylation2▲ 18×3 topics
  14. Immunotherapy2▲ 6.3×5 topics
  15. Anticancer2▲ 19×7 topics
  16. Cancer Therapy2▲ 5.9×7 topics
  17. Hepatoprotective2▲ 48×3 topics
  18. Biomedical Applications1▲ 3.3×7 topics
  19. Medicinal Chemistry1▲ 9.6×4 topics
  20. Pharmacokinetics1▲ 13×6 topics
  21. Genomic Integration1▲ 31×2 topics
  22. Glycyrrhizin1▲ 82×1 topic
  23. Licorice1▲ 82×1 topic
  24. Tumor Targeting1▲ 24×2 topics
  25. Anticancer Agents1▲ 12×5 topics
  26. Drug Delivery1▲ 6.4×2 topics
  27. Tumor Regression1▲ 33×2 topics
  28. Oxidative Stress1▲ 1.58×14 topics
  29. Traditional Chinese Medicine1▲ 17×3 topics
  30. Tumor Microenvironment1▲ 7.3×5 topics

Which research topics does Regenex Pharmaceuticals (China) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Phytochemical and Pharmacological Studies and Digital Transformation in Industry.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  3. 3 Phytochemical and Pharmacological Studies Complementary and alternative medicine 0 works
  4. 4 Digital Transformation in Industry Industrial and Manufacturing Engineering 0 works
  5. 5 Manufacturing Process and Optimization Industrial and Manufacturing Engineering 0 works
  6. 6 Gut microbiota and health Molecular Biology 0 works
  7. 7 HER2/EGFR in Cancer Research Oncology 0 works
  8. 8 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  9. 9 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.9%not open62.1%

World: 28% of research is openly available.

with international co-authors26.7%domestic only73.3%

World: 19% is written across borders.

How has Regenex Pharmaceuticals (China)'s research output changed?

Output in 2018–2022 was 82% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Guangzhou

All research institutions in Guangzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.